The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls

JAMA Dermatology

Volumn 153, Issue 9, 2017, Pages 897-905

  Ring, Hans Christian ^a   Thorsen, Jonathan ^b   Saunte, Ditte M ^a   Lilje, Berit ^c   Bay, Lene ^b   Riis, Peter Theut ^a   Larsen, Niels ^d   Andersen, Lee O’Brien ^c   Nielsen, Henrik V ^c   Miller, Iben M ^a   Bjarnsholt, Thomas ^b   Fuursted, Kurt ^c   Jemec, Gregor Borut ^a  

^a ZEALAND UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

^d Danish Genome Institute   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S; RNA 18S; BACTERIAL DNA;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORYNEBACTERIUM; DENMARK; FEMALE; HUMAN; HUMAN TISSUE; INFORMED CONSENT; MALE; NEXT GENERATION SEQUENCING; NONHUMAN; PATHOGENESIS; PEPTONIPHILUS; PORPHYROMONAS; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; SKIN BIOPSY; SKIN FLORA; SUPPURATIVE HIDRADENITIS; BACTERIUM; DNA SEQUENCE; GENETICS; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; SKIN;

ADULT; BACTERIA; CASE-CONTROL STUDIES; DNA, BACTERIAL; FEMALE; HIDRADENITIS SUPPURATIVA; HUMANS; MALE; MICROBIOTA; MIDDLE AGED; SEQUENCE ANALYSIS, DNA; SKIN;

EID: 85029534056     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2017.0904     Document Type: Article

References (36)

1. Zouboulis CC, Del Marmol V, Mrowietz U, Prens EP, Tzellos T, Jemec GB. Hidradenitis suppurativa/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation. Dermatology. 2015;231(2):184-190.
2. Jemec GB. Clinical practice: hidradenitis suppurativa. N Engl J Med. 2012;366(2):158-164.
3. Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol. 1996;35(2, pt 1):191-194.
4. Vinding GR, Miller IM, Zarchi K, Ibler KS, Ellervik C, Jemec GB. The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa. Br J Dermatol. 2014;170 (4):884-889.
5. Jemec GB, Kimball AB. Hidradenitis suppurativa: epidemiology and scope of the problem. J Am Acad Dermatol. 2015;73(5)(suppl 1):S4-S7.
6. van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, Prens EP. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. Br J Dermatol. 2011;164(6):1292-1298.
7. Giamarellos-Bourboulis EJ, Antonopoulou A, Petropoulou C, et al. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br J Dermatol. 2007;156(1):51-56.
8. Ring HC, Riis Mikkelsen P, Miller IM, et al. The bacteriology of hidradenitis suppurativa: a systematic review. Exp Dermatol. 2015;24(10): 727-731.
9. Sartorius K, Killasli H, Oprica C, Sullivan A, Lapins J. Bacteriology of hidradenitis suppurativa exacerbations and deep tissue cultures obtained during carbon dioxide laser treatment. Br J Dermatol. 2012;166(4):879-883.
10. Lapins J, Jarstrand C, Emtestam L. Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol. 1999;140(1):90-95.
11. Brook I, Frazier EH. Aerobic and anaerobic microbiology of axillary hidradenitis suppurativa. J Med Microbiol. 1999;48(1):103-105.
12. Jemec GB, Faber M, Gutschik E, Wendelboe P. The bacteriology of hidradenitis suppurativa. Dermatology. 1996;193(3):203-206.
13. Matusiak Ł, Bieniek A, Szepietowski JC. Bacteriology of hidradenitis suppurativa: which antibiotics are the treatment of choice? Acta Derm Venereol. 2014;94(6):699-702.
14. Nikolakis G, Join-Lambert O, Karagiannidis I, Guet-Revillet H, Zouboulis CC, Nassif A. Bacteriology of hidradenitis suppurativa/acne inversa: a review. J Am Acad Dermatol. 2015;73(5) (suppl 1):S12-S18.
15. Buchan BW, Ledeboer NA. Emerging technologies for the clinical microbiology laboratory. Clin Microbiol Rev. 2014;27(4):783-822.
16. Hardie JM. Oral microbiology: current concepts in the microbiology of dental caries and periodontal disease. Br Dent J. 1992;172(7):271-278.
17. Murdoch DA. Gram-positive anaerobic cocci. Clin Microbiol Rev. 1998;11(1):81-120.
18. Guet-Revillet H, Coignard-Biehler H, Jais JP, et al. Bacterial pathogens associated with hidradenitis suppurativa, France. Emerg Infect Dis. 2014;20(12):1990-1998.
19. Albert AY, Chaban B, Wagner EC, et al; VOGUE Research Group. A study of the vaginal microbiome in healthy Canadian women utilizing cpn60-based molecular profiling reveals distinct Gardnerella subgroup community state types. PLoS One. 2015; 10(8):e0135620.
20. Hill JE, Goh SH, Money DM, et al. Characterization of vaginal microflora of healthy, nonpregnant women by chaperonin-60 sequence-based methods. Am J Obstet Gynecol. 2005;193(3, pt 1):682-692.
21. Mysak J, Podzimek S, Sommerova P, et al. Porphyromonas gingivalis: major periodontopathic pathogen overview. J Immunol Res. 2014;2014: 476068.
22. Murphy EC, Frick IM. Gram-positive anaerobic cocci: commensals and opportunistic pathogens. FEMS Microbiol Rev. 2013;37(4):520-553.
23. Brook I. Prevotella and Porphyromonas infections in children. J Med Microbiol. 1995;42(5): 340-347.
24. Callewaert C, Kerckhof FM, Granitsiotis MS, Van Gele M, Van de Wiele T, Boon N. Characterization of Staphylococcus and Corynebacterium clusters in the human axillary region. PLoS One. 2013;8(8):e70538.
25. Grice EA, Segre JA. The skin microbiome [published correction appears in Nat Rev Microbiol. 201;9(8):626]. Nat Rev Microbiol. 2011;9(4):244-253.
26. Grice EA, Kong HH, Conlan S, et al; NISC Comparative Sequencing Program. Topographical and temporal diversity of the human skin microbiome. Science. 2009;324(5931):1190-1192.
27. Fitz-Gibbon S, Tomida S, Chiu BH, et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol. 2013;133(9):2152-2160.
28. Sanford JA, Gallo RL. Functions of the skin microbiota in health and disease. Semin Immunol. 2013;25(5):370-377.
29. Kamp S, Fiehn AM, Stenderup K, et al. Hidradenitis suppurativa: a disease of the absent sebaceous gland? sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa. Br J Dermatol. 2011;164(5):1017-1022.
30. Jemec GB, Gniadecka M. Sebum excretion in hidradenitis suppurativa. Dermatology. 1997;194 (4):325-328.
31. van der Zee HH, de Ruiter L, Boer J, et al. Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions. Br J Dermatol. 2012;166(1):98-106.
32. Ring HC, Bay L, Kallenbach K, et al. Normal skin microbiota is altered in pre-clinical hidradenitis suppurativa. Acta Derm Venereol. 2017;97(2): 208-213.
33. Jemec GB, Hansen U. Histology of hidradenitis suppurativa. J Am Acad Dermatol. 1996;34(6): 994-999.
34. von Laffert M, Helmbold P, Wohlrab J, Fiedler E, Stadie V, Marsch WC. Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis. Exp Dermatol. 2010;19(6):533-537.
35. Nakatsuji T, Chiang HI, Jiang SB, Nagarajan H, Zengler K, Gallo RL. The microbiome extends to subepidermal compartments of normal skin. Nat Commun. 2013;4:1431.
36. Callewaert C, Hutapea P, Van de Wiele T, Boon N. Deodorants and antiperspirants affect the axillary bacterial community. Arch Dermatol Res. 2014;306(8):701-710.